Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ultrasound-guided intra-articular bone marrow aspirate concentrate versus platelet-rich plasma versus hyaluronic acid for chronic knee osteoarthritis pain
PACTR202607608327898Phase 3Completed
- Sponsor
- Mohamed Nassar
- Start
- Sep 2023
- Modality
- Stem Cell Therapies → Cell Therapies
- Countries
- 1
01
Overview
Phase 3, open-label trial of autologous bone marrow cell concentrate, platelet-rich plasma and hyaluronic acid in knee osteoarthritis (OA), sponsored by Mohamed Nassar. Started Sep 2023; status: completed.
02
Drugs
autologous bone marrow cell concentrateplatelet-rich plasmahyaluronic acid
03
Conditions
knee osteoarthritis (OA)
Beyond the preview
Go deeper on PACTR202607608327898.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR202607608327898.